Cargando…
Sacituzumab govitecan for breast cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427618/ https://www.ncbi.nlm.nih.gov/pubmed/36110167 http://dx.doi.org/10.18773/austpresr.2022.042 |
_version_ | 1784778946253946880 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9427618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-94276182022-09-14 Sacituzumab govitecan for breast cancer Aust Prescr New Drugs NPS MedicineWise 2022-07-07 2022-08 /pmc/articles/PMC9427618/ /pubmed/36110167 http://dx.doi.org/10.18773/austpresr.2022.042 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | New Drugs Sacituzumab govitecan for breast cancer |
title | Sacituzumab govitecan for breast cancer |
title_full | Sacituzumab govitecan for breast cancer |
title_fullStr | Sacituzumab govitecan for breast cancer |
title_full_unstemmed | Sacituzumab govitecan for breast cancer |
title_short | Sacituzumab govitecan for breast cancer |
title_sort | sacituzumab govitecan for breast cancer |
topic | New Drugs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427618/ https://www.ncbi.nlm.nih.gov/pubmed/36110167 http://dx.doi.org/10.18773/austpresr.2022.042 |